These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6113394)

  • 1. Partial preservation of pancreatic beta-cell function in children with diabetes.
    Elliott RB; Crossley JR; Berryman CC; James AG
    Lancet; 1981 Jul; 2(8236):1-4. PubMed ID: 6113394
    [No Abstract]   [Full Text] [Related]  

  • 2. Partial preservation of pancreatic beta-cell function in children with diabetes.
    Lancet; 1981 Aug; 2(8241):311. PubMed ID: 6114355
    [No Abstract]   [Full Text] [Related]  

  • 3. Factors of importance for residual beta-cell function in type I diabetes mellitus. A review.
    Madsbad S
    Acta Med Scand Suppl; 1983; 671():61-7. PubMed ID: 6349267
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors predicting residual beta-cell function in the first year after diagnosis of childhood type 1 diabetes.
    Couper JJ; Hudson I; Werther GA; Warne GL; Court JM; Harrison LC
    Diabetes Res Clin Pract; 1991 Jan; 11(1):9-16. PubMed ID: 2019237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of a somatostatin analog for preserving beta cell function in children with insulin dependent diabetes mellitus.
    Grunt JA; al-Hakim H; Willoughby L; Howard CP
    J Pediatr Endocrinol; 1994; 7(4):331-4. PubMed ID: 7735371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between GAD antibody and residual beta-cell function in children after overt onset of IDDM.
    Yokota I; Shirakawa N; Shima K; Matsuda J; Naito E; Ito M; Kuroda Y
    Diabetes Care; 1996 Jan; 19(1):74-5. PubMed ID: 8720540
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of nicotinamide therapy upon B-cell function in newly diagnosed type 1 (insulin-dependent) diabetic patients.
    Mendola G; Casamitjana R; Gomis R
    Diabetologia; 1989 Mar; 32(3):160-2. PubMed ID: 2526767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of predictors of beta-cell survival in type I diabetes.
    Schiffrin A; Suissa S; Poussier P; Guttmann R; Weitzner G
    Diabetes; 1988 Jul; 37(7):920-5. PubMed ID: 3290010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immune response to GAD in type 1 diabetes with residual beta-cell function.
    Fukui M; Nakamura N; Nakano K; Kondo M
    Diabetes Care; 1999 Oct; 22(10):1758-9. PubMed ID: 10526760
    [No Abstract]   [Full Text] [Related]  

  • 10. [Type LADA diabetes--interrogation points].
    Otto-Buczkowska E
    Przegl Lek; 2013; 70(1):25-7. PubMed ID: 23789301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cyclosporin A on B-cell loss in type 1 (insulin-dependent) diabetes mellitus.
    Vague P; Vialettes B; Picq R; Dol S; Lassmann-Vague V
    Diabetologia; 1989 Dec; 32(12):887. PubMed ID: 2693167
    [No Abstract]   [Full Text] [Related]  

  • 12. Temporary preservation of beta-cell function by diazoxide treatment in childhood type 1 diabetes.
    Ortqvist E; Björk E; Wallensteen M; Ludvigsson J; Aman J; Johansson C; Forsander G; Lindgren F; Berglund L; Bengtsson M; Berne C; Persson B; Karlsson FA
    Diabetes Care; 2004 Sep; 27(9):2191-7. PubMed ID: 15333483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmapheresis in the initial treatment of insulin-dependent diabetes mellitus in children.
    Ludvigsson J; Heding L; Liedén G; Marner B; Lernmark A
    Br Med J (Clin Res Ed); 1983 Jan; 286(6360):176-8. PubMed ID: 6401518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus.
    Silverstein J; Maclaren N; Riley W; Spillar R; Radjenovic D; Johnson S
    N Engl J Med; 1988 Sep; 319(10):599-604. PubMed ID: 3045545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of i.v. tolbutamide on alpha- and beta-cell secretion in type I diabetes].
    Verga S; Donatelli M; Cerasola G; Sinagra D; Inglese CG; Terrizzi C
    Minerva Endocrinol; 1984; 9(3):339-42. PubMed ID: 6398400
    [No Abstract]   [Full Text] [Related]  

  • 16. [Islands of Langerhans' autoantibodies in patients with insulin-dependent diabetes mellitus].
    Gomes MB; Quadra AA; Vieira LM; Sarno EN
    AMB Rev Assoc Med Bras; 1985; 31(3-4):59-61. PubMed ID: 3909246
    [No Abstract]   [Full Text] [Related]  

  • 17. Investigations in children who were in utero at onset of insulin-dependent diabetes in their mothers.
    Buschard K; Kühl C; Mølsted-Pedersen L; Lund E; Palmer J; Bottazzo GF
    Lancet; 1989 Apr; 1(8642):811-4. PubMed ID: 2564904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-peptide/creatinine ratio in early morning urine as an indicator of residual B-cell function in insulin-dependent diabetes.
    Sasaki N; Miyamoto S; Niimi H; Nakajima H
    Acta Paediatr Jpn; 1991 Jun; 33(3):375-80. PubMed ID: 1785335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset.
    Stiller CR; Dupré J; Gent M; Jenner MR; Keown PA; Laupacis A; Martell R; Rodger NW; von Graffenried B; Wolfe BM
    Science; 1984 Mar; 223(4643):1362-7. PubMed ID: 6367043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.
    Keymeulen B; Vandemeulebroucke E; Ziegler AG; Mathieu C; Kaufman L; Hale G; Gorus F; Goldman M; Walter M; Candon S; Schandene L; Crenier L; De Block C; Seigneurin JM; De Pauw P; Pierard D; Weets I; Rebello P; Bird P; Berrie E; Frewin M; Waldmann H; Bach JF; Pipeleers D; Chatenoud L
    N Engl J Med; 2005 Jun; 352(25):2598-608. PubMed ID: 15972866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.